Anika Therapeutics (ANIK) Divestments (2025)

Anika Therapeutics (ANIK) reported Divestments of $4.5 million for Q1 2025.

Anika Therapeutics (ANIK) Divestments (2025) Analysis & Trends

Anika Therapeutics (ANIK) has 1 years of Divestments data on file, last reported at $4.5 million in Q1 2025.

  • Divestments for Q1 2025 came in at $4.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $4.5 million (changed N/A YoY), and the FY2025 annual result was $4.5 million, changed N/A from the prior year.
  • Divestments was little changed at $4.5 million in Q1 2025 per ANIK's latest filing.
  • Over five years, Divestments peaked at $4.5 million in Q1 2025 and troughed at $4.5 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 42.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 63.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 24.21 Mn
10 Anika Therapeutics 197.89 Mn 131.10 Mn 19.00 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 4.50 Mn